Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Phase of Trial: Phase III
Latest Information Update: 08 May 2015
Price : $35 *
At a glance
- Drugs Tadalafil (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms PITCH-HF
- 19 Feb 2014 Status changed from active, no longer recruiting to discontinued according to ClinicalTrials.gov record.
- 26 Jan 2014 New source identified and integrated (Oregon Health and Science University Institutional Review Board).
- 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.